NeuBase Therapeutics, Inc.

CIK 1173281 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NeuBase Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jan 13, 202515-12G0001104659-25-003052
Jan 7, 20258-K0001104659-25-001664
Jul 2, 2024EFFECT9999999995-24-002049
Jul 2, 2024EFFECT9999999995-24-002048
Jun 27, 202415-12G0001104659-24-075760
Jun 27, 2024S-8 POS0001104659-24-075718
Jun 27, 20248-K0001104659-24-075711
Jun 27, 2024S-8 POS0001104659-24-075747
Jun 27, 2024S-8 POS0001104659-24-075742
Jun 27, 2024S-8 POS0001104659-24-075750
Jun 27, 2024POS AM0001104659-24-075714
Jun 27, 2024POS AM0001104659-24-075712
Jun 27, 2024S-8 POS0001104659-24-075744
Jun 3, 2024DEFA14A0001104659-24-067779
May 31, 20248-K0001104659-24-067212
May 22, 20248-K0001104659-24-064320
May 16, 202425-NSE0001354457-24-000350
May 14, 2024DEFA14A0001104659-24-060759
May 13, 20248-K0001104659-24-060568
May 6, 2024DEFA14A0001104659-24-057213
May 3, 20248-K0001104659-24-056957
Apr 9, 2024DEF 14A0001104659-24-045207
Apr 5, 20248-K0001104659-24-044287
Mar 25, 2024PRE 14A0001104659-24-038432
Mar 7, 20248-K0001104659-24-031876